Corticosteroids and Outcomes in Solid Organ Transplant Recipients Infected With Severe Acute Respiratory Syndrome Coronavirus 2

© 2023 The Authors..

Objective: To examine outcomes in organ transplant and nontransplant patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during the initial 22 months of the pandemic.

Patients and Methods: We used Optum electronic health records to compare outcomes between an adult transplant group and a propensity-matched nontransplant group that tested positive for SARS-CoV-2 from February 1, 2020, to December 15, 2021. Baseline characteristics, hospitalization, intensive care unit admission, mechanical ventilation, renal replacement therapy, inpatient, and 90-day mortality were compared between the transplant and nontransplant groups and among specific transplant recipients. Cox proportional analysis was used to examine hospitalization and mortality by organ transplant, medical therapy, sex, and the period of the pandemic.

Results: We identified 876,959 patients with SARS-CoV-2 infection, of whom 3548 were organ transplant recipients. The transplant recipients had a higher risk of hospitalization (30.6% vs 25%, respectively; P<.001), greater use of mechanical ventilation (7.8% vs 5.6%, respectively; P<.001), and increased inpatient mortality (6.7% vs 4.7%, respectively; P<.001) compared with the nontransplant patients. The initiation of mechanical ventilation was significantly more frequent in the transplant group. After adjustment for baseline characteristics and comorbidities, the transplant group had a higher risk of hospitalization (odds ratio, 1.38; 95% confidence interval, 1.19-1.59), without a difference in mortality. In the transplant group, lung transplant recipients had the highest inpatient mortality (11.6%).

Conclusion: Among patients with SARS-CoV-2 infection, the transplant recipients were at a higher risk of hospitalization and inpatient mortality; however, mortality was mainly driven by advanced age and comorbidities rather than by transplant status or immunosuppressive medications. Lung transplant recipients had the greatest inpatient and 90-day mortality.

Medienart:	E-Artikel

Erscheinungsjahr:	2023
Erschienen:	2023

Enthalten in:	Zur Gesamtaufnahme - volume:7
Enthalten in:	Mayo Clinic proceedings. Innovations, quality & outcomes - 7(2023), 2 vom: 06. Apr., Seite 99-108

Sprache:	Englisch

Beteiligte Personen:	Nada, Khaled M [VerfasserIn] Polychronopoulou, Efstathia [VerfasserIn] Sharma, Gulshan [VerfasserIn] Duarte, Alexander G [VerfasserIn]

Links:	Volltext

Themen:	CI, confidence interval COVID-19, coronavirus disease 2019 ICD-10, International Classification for Diseases, tenth revision ICU, intensive care unit Journal Article OR, odds ratio SARS-CoV-2, severe acute respiratory syndrome coronavirus 2

Anmerkungen:	Date Revised 06.03.2023 published: Print-Electronic Citation Status PubMed-not-MEDLINE

doi:	10.1016/j.mayocpiqo.2023.01.002

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	NLM352875224